$116.22
+2.09 (+1.83%)
At Close: Jun 03, 2026
Drug costs for COVID-19 patients plunge at U.S. hospitals, but may rise
11:00am, Wednesday, 19'th Aug 2020
Medication costs for COVID-19 patients hospitalized in the United States have dropped sharply since May, reflecting advances in treatment, shorter stays and use of cheaper generic drugs. Research by
Stocks - Wall Street Opens Mixed as Target, Lowe's Surge; Dow up 30 Pts
09:35am, Wednesday, 19'th Aug 2020
By Geoffrey Smith
Gilead arthritis drug won't be approved by FDA in current form, partner Galapagos says
07:46am, Wednesday, 19'th Aug 2020
Gilead Sciences investigational treatment for moderately to severely active rheumatoid arthritis won't be approved by the U.S. Food and Drug Administration in current form, its partner Galapagos sai
Gilead Sinks After-Hours As FDA Rejects Rheumatoid Arthritis Application
06:48am, Wednesday, 19'th Aug 2020
Gilead Sciences (GILD) has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) for filgotinib, an investigational treatment fo
Gilead Receives Complete Response Letter for Filgotinib for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
11:25pm, Tuesday, 18'th Aug 2020
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the New Drug Application (NDA) for filgotinib, an
Gilead announces another cancer deal
12:18pm, Tuesday, 18'th Aug 2020
Shares of Gilead Sciences Inc. gained 0.3% in premarket trading on Tuesday after the drugmaker on Monday evening announced a deal worth more than $6 billion with Tango Therapeutics. The collaboration
Gilead ‘Very Pleased’ With Tango Collab, Boosts Cancer Targets To 15
07:27am, Tuesday, 18'th Aug 2020
Gilead Sciences (GILD) and Tango Therapeutics have announced an expanded collaboration focusing on targeted immune evasion therapies for cancer patients.Under the deal, which builds on a previous 2018
Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration
08:05pm, Monday, 17'th Aug 2020
Gilead Sciences, Inc. (Nasdaq: GILD) and Tango Therapeutics today announced an expanded strategic collaboration focused on the discovery, development and commercialization of innovative targeted immun
Merck Is Barron’s Stock Pick This Week’s. Here’s Why.
07:30pm, Saturday, 15'th Aug 2020
Shares of Merck (ticker: MRK), now around $83, are down 8% this year. For investors looking for a strong pharmaceutical play at a reasonable price, Merck should get attention. “Merck speaks softly
Merck, Big Pharma’s Quiet Giant, Looks Like a Buy
07:40pm, Friday, 14'th Aug 2020
Shares of Merck (ticker: MRK), now around $83, are down 8% this year. For investors looking for a strong pharmaceutical play at a reasonable price, Merck should get attention. “Merck speaks softly
A Field Guide to Covid-19 Vaccines and Antivirals
08:55pm, Thursday, 13'th Aug 2020
Canadian small-cap biotech CytoDyn has asked the FDA to grant the company’s drug, Leronlimab, an emergency-use authorization to treat mild to moderate Covid-19 cases.
Zydus Cadila launches India's cheapest remdesivir version at $37 per vial
04:14am, Thursday, 13'th Aug 2020
Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences' antiviral drug remdesivir in India to treat COVID-19 following reports of shortages at hospitals in the world's third
CalPERS more than doubles Gilead and Zoom Video stakes, trims Apple and Microsoft
06:35pm, Wednesday, 12'th Aug 2020
California Public Employees Retirement System (CalPERS) disclosed Wednesday that it more than doubled its shares stakes in Gilead Sciences Inc. and Zoom Video Communications Inc. , both of which have
Is Diodes (NASDAQ:DIOD) Using Too Much Debt?
12:25pm, Wednesday, 12'th Aug 2020
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Is Now The Time To Look At Buying Diodes Incorporated (NASDAQ:DIOD)?
12:21pm, Wednesday, 12'th Aug 2020
Diodes Incorporated (NASDAQ:DIOD), is not the largest company out there, but it received a lot of attention from a...
Sign In
Buy DIOD